Management of unstable angina and non-ST-segment elevation myocardial infarction
H G Hanley1, T M Nylk, N Nguyen
1Cardiology Section, Louidisns State University Health Sciences Center, Department of Internal Medicine, Shreveport, Louisiana, USA.
Insights
Current acute coronary syndrome (ACS) treatments include aspirin, nitrates, and anticoagulation. New agents like low molecular weight heparins and ADP inhibitors improve prognosis, alongside an early invasive approach for high-risk patients.
Area of Science:
- Cardiology
- Internal Medicine
Background:
- Acute coronary syndromes (ACS) commonly present as unstable angina or non-ST-segment elevation myocardial infarction.
- Recent advancements in diagnosis and treatment have led to updated management guidelines for improved patient outcomes.
Purpose of the Study:
- To review current knowledge on managing unstable angina and non-ST-segment elevation myocardial infarction.
- To present established and emerging treatment strategies for these conditions.
Main Methods:
- Review of established pharmacological treatments including aspirin, nitrates, beta-blockers, calcium channel blockers, and unfractionated heparin.
- Evaluation of newer therapeutic agents such as low molecular weight heparins, ADP inhibitors, and glycoprotein IIb/IIIa blockers.
- Consideration of treatment approaches, including the role of early invasive strategies.
Main Results:
- Traditional therapies remain effective and are recommended.
- Novel anticoagulants and antiplatelet agents offer significant benefits and improved patient prognosis.
- An early invasive approach is increasingly recognized as the standard of care, particularly for high-risk individuals.
Conclusions:
- Modern pharmacotherapy, including novel agents, enhances treatment efficacy for ACS.
- An early invasive strategy is pivotal for optimizing outcomes in high-risk ACS patients.
Abstract:
Most of the patients with acute coronary syndromes present with unstable angina or non-ST-segment elevation myocardial infarction. Recent advances in the diagnosis and treatment of these conditions have changed the management guidelines, allowing for better patient care. The purpose of this review is to summarize the current knowledge and present both established and new or evolving strategies used in the treatment of patients with unstable angina and non-ST-segment elevation myocardial infarction. Use of aspirin, nitrates, beta-blockers, calcium channel blockers, and anticoagulation with unfractionated heparin has been a common practice in these patients. While still effective and recommended, the emergence of new anticoagulants (low molecular weight heparins) and antiplatelet agents (ADP inhibitors and glycoprotein IIb/IIIa blockers) has added significant benefit to the treatment options and has resulted in a better prognosis for the patients. It also appears that, in view of recent trials, an early invasive approach is becoming the standard of care, especially for high-risk patients.
More Related Videos
05:26Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
Related Concept Videos
01:30Acute Coronary Syndrome I: Introduction
01:28Acute Coronary Syndrome IV: Interprofessional Care
01:26Acute Coronary Syndrome V: Nursing Management
01:27Angina II: Classification
01:26Angina IV: Management
01:20Angina V: Nursing Management